Influence of the Timing of Leptomeningeal Metastasis on the Outcome of <i>EGFR</i>-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable <i>EGFR</i> Mutations in Cerebrospinal Fluid
Background: We aim to evaluate the influence of the timing of leptomeningeal metastasis (LM) occurrence on the outcome of <i>EGFR</i>-mutant lung adenocarcinoma and to explore the predictors of detectable <i>EGFR</i> mutation in the cerebrospinal fluid (CSF). Methods: <i&g...
Main Authors: | Pei-Ya Liao, Wei-Fan Ou, Kang-Yi Su, Ming-Hsi Sun, Chih-Mei Huang, Kun-Chieh Chen, Kuo-Hsuan Hsu, Sung-Liang Yu, Yen-Hsiang Huang, Jeng-Sen Tseng, Tsung-Ying Yang, Gee-Chen Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/12/2824 |
Similar Items
-
EGFR amplification indicated poor prognosis in EGFR‐mutated lung cancer with leptomeningeal metastases
by: Di Geng, et al.
Published: (2024-02-01) -
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases
by: Mei-Mei Zheng, et al.
Published: (2022-05-01) -
Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing
by: Hainan Yang, et al.
Published: (2022-05-01) -
Potential benefit of osismertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
by: Yali Yi, et al.
Published: (2022-03-01) -
Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases
by: Mengxi Ge, et al.
Published: (2019-02-01)